Researchers at the University of California San Diego have developed an artificial intelligence system that could revolutionise precision oncology by identifying key genomic alterations directly from tumour biopsy images, potentially saving crucial time and resources in cancer treatment.
Researchers at the Max Delbrück Center have developed an open-source platform called Open-ST that creates high-resolution 3D maps of gene expression in tissue samples, potentially revolutionising our understanding of disease processes and enhancing clinical pathology.
Scientists in the UK have developed the first code of practice for research using stem cell-based embryo models, providing ethical guidelines and governance for this rapidly advancing field.
Rice University bioengineers have developed the smallest free-floating gas-filled structures for medical imaging, potentially revolutionising ultrasound technology and targeted drug delivery.
A team at the University of Bonn has established a highly efficient and cost-effective technique to produce functional endothelial cells from human induced pluripotent stem cells, potentially advancing cardiovascular disease research and organoid development. Scientists at the University Hospital Bonn (UKB) and the University of Bonn have made significant strides in the field of cardiovascular […]
The European Laboratory Research & Innovation Group (ELRIG) UK and The Protein Society (TPS) have announced a partnership aimed at advancing protein sciences in drug discovery. This collaboration will culminate in a joint conference, ‘Protein Sciences in Drug Discovery’, scheduled for 18-19 November 2024 in Cambridge, UK.
In a move set to advance the lab informatics landscape, Sapio Sciences has launched its Partner Programme. This initiative aims to foster a robust ecosystem of technology vendors, service providers, and resellers, equipping them with essential resources to deliver cutting-edge solutions for scientists.
A new partnership between Surfix Diagnostics, the Netherlands Cancer Institute (NKI), and CRCbioscreen will focus on the validation of novel biomarkers for colorectal cancer (CRC) screening. The collaboration, supported by a PPP grant from the TKI-program Life Sciences & Health of Health~Holland, aims to address the limitations of current screening methods and potentially revolutionise early […]
Munich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]
Newcastle-based drug discovery partner Newcells Biotech has appointed Emile Shaffu as Director of Sales. This strategic move aims to strengthen the company’s global market presence and enhance customer support in the field of in vitro models and bespoke assay services.
May 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.